About Publications

Publications from the National Academies of Sciences, Engineering, and Medicine provide objective and straightforward advice to decision makers and the public. This site includes Health and Medicine Division (HMD) publications released after 1998. A complete list of HMD’s publications from its establishment in 1970 to the present is available as a PDF.


  • The National Cancer Policy Summit: Opportunities and ... Released: February 28, 2011
    Technological advances are altering the way cancer research is conducted and cancer care is delivered, and research increasingly is an international effort. At the same time, research budgets are shrinking and the cost of care is growing. The National Cancer Policy Summit brought together leaders in the cancer community to discuss these changes in research and care. Participants suggested many potential actions to provide more patient-centered cancer care, foster more collaboration, and achieve other goals to improve research and care.
  • Nanotechnology and Oncology – Workshop Summary : Health ... Released: February 25, 2011
    One way scientists are working to overcome challenges in cancer treatment and improve cancer care is through nanotechnology. The National Cancer Policy Forum held a workshop July 12-13, 2010, to explore challenges in the use of nanotechnology in oncology.
  • The Healthcare Imperative: Lowering Costs and Improving ... Released: February 24, 2011
    The Roundtable on Value & Science-Driven Health Care held a three-part workshop series to explore opportunities to reduce health care costs without compromising health status, quality of care, or innovation.
  • Clinical Data as the Basic Staple of Health Learning ... Released: February 03, 2011
    Successful development of clinical data as an engine for knowledge generation has the potential to transform health and health care in America. As part of its Learning Health System Series, the Roundtable on Value & Science-Driven Health Care hosted a workshop to discuss expanding the access to and use of clinical data as a foundation for care improvement.
  • Sex Differences and Implications for Translational ... Released: December 10, 2010
    Biological differences between the sexes influence not only individual health but also public health, biomedical research, and health care. The IOM held a workshop March 8-9, 2010, to discuss sex differences and their implications for translational neuroscience research, which bridges the gap between scientific discovery and application.
  • Future Opportunities to Leverage the Alzheimer's Disease ... Released: December 10, 2010
    Nearly 5.3 million Americans are living with Alzheimer’s disease, and 26.6 million people are affected worldwide. The Alzheimer’s Disease Neuroimaging Initiative (ADNI), a public-private partnership, provides a publicly available, international database of clinical and imaging data to foster research and collaboration on Alzheimer’s research worldwide. The IOM held a workshop on July 12, 2010, to explore opportunities to use information from and partnerships formed because of ADNI to continue to improve the understanding and treatment of Alzheimer’s disease.
  • Redesigning the Clinical Effectiveness Research Paradigm ... Released: December 06, 2010
    Currently, a substantial gap exists between the knowledge needed and that available for medical care decisions. The IOM Roundtable on Value & Science-Driven Health Care sponsored a meeting to explore the methods, data resources, tools, and techniques that are emerging in the new generation of accelerated clinical research approaches.
  • Certifying Personal Protective Technologies: Improving ... Released: November 11, 2010
    Millions of workers in worksites across the United States rely on personal protective technologies (PPT) to guard them against injury, illness, or death. At the request of the National Institute for Occupational Safety and Health, the IOM examined the various approaches cur¬rently used to certify the effectiveness of PPT; to review the standards and regulations that cover PPT; and to assess the benefits of certification to worker safety.
  • Rare Diseases and Orphan Products: Accelerating Research ... Released: October 04, 2010
    Rare diseases collectively affect millions of Americans of all ages, but developing drugs and medical devices to prevent, diagnose, and treat these conditions is challenging. The IOM recommends implementing an integrated national strategy to promote rare diseases research and product development.
  • Extending the Spectrum of Precompetitive Collaboration in ... Released: July 22, 2010
    The IOM’s National Cancer Policy Forum held a workshop February 9-10, 2010, to explore the growing importance of precompetitive collaboration in oncology drug development. Speakers discussed the advantages and challenges of collaborating with competitors to achieve goals with the potential to benefit everyone, and offered lessons learned and best practices to facilitate future precompetitive collaboration.